Public Health

MassBio Recognizes Three Biotech and Pharma Companies with Awards at Annual State of Possible Conference

April 25, 2024

Morphoceuticals Names Jim Jenson, PhD as CEO to Advance AI-Guided Regenerative Medicine Technology

April 18, 2024

PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions

April 9, 2024

New England Biolabs Leases 28,000 SF

December 7, 2020

Walgreens Boots Alliance Appoints Bryan C. Hanson to Board of Directors

October 28, 2022

Immunology biotech firm to relocate from Cambridge to Woburn

November 18, 2021

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Tufts Medicine, Navvis Partner to Accelerate Value-Based Care, Driving Healthcare Transformation in Massachusetts

athenahealth and the American Council of the Blind Collaborate to Expand Digital Accessibility for athenahealth Patients

State of U.S. Health Care is in Crisis; The Physicians Foundation Calls for Convergence of Efforts to Address Drivers of Health

Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks

XiFin to Highlight Impact of FDA Regulations, Other Disruptive Forces Facing Hospitals, Independent Labs, and Pathology Practices at 29th Annual Executive War College

Most Read

Manulife Investment Management Announces Forest Climate Fund’s Second Close Bringing Total Commitments Up to $334.5 Million

U.S. FDA Approves Pfizer’s BEQVEZ™, a One-Time Gene Therapy for Adults with Hemophilia B

LumaBridge Appoints Todd Lehman as Chief Executive Officer

Invensify Introduces the Industry’s Most Energy Efficient Cold Chain Shipping Transporter

EDITOR PICKS